Zinwi Biotech granted the first electronic cigarette production license in China

On June 15th, Shenzhen Zinwi Biotech Co., Ltd. (hereinafter referred to as "Zinwi Biotech") was granted the first tobacco monopoly production license (aerosol) in the electronic cigarette industry, marking Zinwi Biotech as the leading enterprise in the aerosol sub-sector, having passed the strict review of the State Tobacco Monopoly Administration, becoming one of the few enterprises authorized with a tobacco monopoly production license.

The issuance of the tobacco monopoly production license means that China has taken an important and solid step in promoting the legalization and standardization of the electronic cigarette industry. Under the new industry structure, Zinwi Biotech will continue to adhere to the principle of "putting national interests and consumers' interests first", and with the mission of "leading the industry development and aerosolizing healthy living", it is committed to becoming a trusted customer, happy employee, and leading global electronic aerosol solution service platform.

Since the implementation of the "Electronic Cigarette Management Regulations" on May 1st, 2022, the State Tobacco Monopoly Administration has rapidly promoted the supervision of new tobacco products such as electronic cigarettes, demonstrating the country's determination to promote the standardized development of the electronic cigarette industry and effectively raising the industry's entry barriers. Zinwi Biotech actively embraces supervision and operates in compliance with laws and regulations, coupled with its long-term good reputation in the industry, it is expected to further increase its market share in the future benign competition of the industry, with its first-mover advantage.

At the same time, China's electronic cigarette industry, which already accounts for more than 90% of global production capacity, will also further consolidate its industry cluster advantages and gain international market recognition under standardized supervision, contributing to the country's revenue and foreign exchange earnings. With the entire industry chain of electronic cigarettes managed according to the standards of conventional cigarettes, including raw materials, production, wholesale, sales, and exports, product quality is effectively supervised, which also better protects consumer rights. Zinwi Biotech will actively implement the principle of "putting both interests first" and embrace new supervision, contributing its efforts to the sustainable development of the electronic cigarette industry!

About Zinwi Biotech

Shenzhen Zinwi Bio-tech Co., Ltd. was established in 2016, with its headquarters located in Guangming District, Shenzhen. It is a national high-tech enterprise that integrates research and development, production, and sales. Since its establishment, the company has been deeply involved in the field of electronic aerosol liquid, and has developed into a global leader in electronic aerosol liquid solution service platforms with strong research and development technical strength, strict quality control processes, and high-quality customer networks.

The company focuses on product research and development and technological innovation, and emphasizes strict quality control, constantly expanding its market. In terms of research and development and technological innovation, the company focuses on the research and application of harm-reducing aerosol technology and established the Aerosol Technology Research Institute led by a team of doctors in 2020. The research and development team is proactive, constantly breaking through industry technological barriers, and has obtained over 200 patents that are in the process of being approved. The company has dozens of experienced professional flavorists and has developed tens of thousands of electronic aerosol liquid product formulations.

In terms of production and quality control, the company has been recognized by multiple authoritative domestic and foreign organizations, including "National CNAS Laboratory Certification," "ISO9001 Quality System Certification," and "GMP Workshop Certification," among others. The company's products are sold to dozens of countries and regions around the world, including Europe, America, the Middle East, Russia, and Canada. They have gained unanimous recognition from more than 300 brand customers and established long-term stable strategic partnerships with many international top brands.

In the future, Zinwi Biotech will continue to uphold the mission of "Driven by Innovation, Exploring the Future," and strive to become a trusted customer, happy employee, and industry-leading global e-liquid solution service platform.